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Article abs t racCThe goal of this study was to characterize the changes in cognition associated with the earliest, or 
preclinical, stages of dementia in Parkinson’s disease (PD). We administered a comprehensive neuropsychological test 
battery to a group of initially nondemented PD patients participating in a longitudinal community-based epidemiologic 
study. We used Cox proportional hazards models to assess the relative risk of incident dementia associated with base- 
line scores on the neuropsychological tests. Baseline performance on two verbal fluency tasks (letter fluency and cate- 
gory fluency) was significantly and independently associated with incident dementia. Tests of memory, orientation, ab- 
stract reasoning, naming, and constructional skill were less sensitive predictors of subsequent dementia. The neu- 
ropsychological pattern characterizing the preclinical stages of dementia in PD differed from that described previously 
in preclinical Alzheimer’s disease. Results suggest that poor performance on tests of verbal fluency may represent a 
distinct characteristic of the preclinical phase of dementia in PD. 
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Recent reports from several prospective longitudi- 
nal studies of aging and dementia have indicated 
that, in healthy older adults who later develop de- 
mentia, neuropsychological tests can detect subtle 
cognitive changes well before the overt clinical 
signs of dementia are evident. The stage of the de- 
generative process prior to the clinical diagnosis of 
dementia, when only subtle or circumscribed cogni- 
tive deficits are evident, has been termed the “pre- 
clinical phase” of dementing i1lness.l Masur et a12 
followed 3 17 initially nondemented participants in 
the Bronx Aging Study for at least 4 years. Using 
logistic regression, they found that four measures 
of cognitive function from the baseline assessment 
identified one subgroup of subjects with an 85% 
probability of developing dementia during the fol- 
low-up period and another group with a 95% proba- 
bility of remaining dementia-free. Similarly, we ex- 
amined the associations between baseline neu- 
ropsychological test scores and subsequent develop- 
ment of dementia in 443 initially nondemented 
participants in a community-based, epidemiologic 
study of dementia in northern Manhattan, NY.3 
Using Cox proportional hazards models, we found 
that scores on the Boston Naming Test,4 immediate 
recall on the Selective Reminding Test,5 and the 
Similarities subtest of the Wechsler Adult Intelli- 
gence Scale-Revised6 were significantly and inde- 
pendently associated with la te r  diagnosis of 
Alzheimer’s disease (AD). 
There have been no prospective, longitudinal 
studies focusing on the neuropsychological mani- 
festations of preclinical dementia in patients with 
Parkinson’s disease (PD). Cross-sectional neuropsy- 
chological investigations examining specific do- 
mains of cognitive function in PD have indicated 
that, relative to age-matched normal controls, non- 
demented patients with PD are impaired on tasks 
requiring such cognitive abilities as verbal flu- 
e n ~ y , ~ - l ~  executive f u n c t i ~ n s , ~ . ~ ~ - l ~  visuospatial 
skills,17-19 and recall memory.20~21 Longitudinal fol- 
low-up of these patients would be useful in illumi- 
nating whether these relative impairments remain 
circumscribed to specific cognitive domains or are 
early manifestations of dementia. To address this 
issue, we followed a cohort of initially nondemented 
PD patients for at least 1 year. We then examined 
the relative risk of incident dementia associated 
with scores on neuropsychological tests adminis- 
tered at  baseline. 
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Methods. Subjects. Data were obtained from subjects 
participating in a community-based, epidemiologic study 
of PD and related disorders in northern Manhattan, NY. 
Establishment of the cohort has been described in detail 
elsewhere.” Briefly, subjects were identified through the 
development of a “registry” for PD and related disorders. 
Sources of patients included regional hospitals, private 
practitioners, health maintenance organizations, senior 
centers, government agencies, and newspaper and radio 
announcements. 
Subjects included in the analyses presented here had 
completed at least one annual follow-up evaluation in ad- 
dition to the baseline assessment. Because we were in- 
terested in defining the neuropsychological characteris- 
tics of preclinical dementia in PD, subjects diagnosed as 
demented at their initial assessment were excluded from 
these analyses. In addition, subjects with a history of 
stroke prior to the baseline assessment were excluded. 
Procedures. Subjects were evaluated annually and re- 
ceived the same standardized neurologic and neuropsycho- 
logical assessment at each study visit. One of three physi- 
cians (K.M., L.J.C., or R.M.) conducted a standardized 
physical and neurologic examination to confirm the diag- 
nosis of PD and recorded each subject’s medical history. 
Idiopathic PD was defined by clinical and research crite- 
ria.23-25 We excluded patients with secondary par- 
kinsonism resulting from phenothiazines, alphamethyl- 
dopa, reserpine, or metaclopramide hydrochloride. Pa- 
tients with clinical presentations suggestive of progressive 
supranuclear palsy, essential tremor, Shy-Drager syn- 
drome, presumed striatonigral degeneration, and olivo- 
pontocerebellar atrophy were also excluded. Motor signs 
and symptoms were rated using the Unified Parkinson’s 
Disease Rating Scale (UPDRS).26 Symptoms of depression 
were rated using the Hamilton Depression Rating Scale.27 
The neuropsychological battery was designed to be 
brief yet also to assess a broad range of cognitive func- 
tions. Evaluations were conducted in either English or 
Spanish, based on the subject’s primary language and 
opinion of which language would yield better perfor- 
mance. To assure comparability of evaluations in English 
and Spanish, all interview questions, test instructions, 
and stimuli were translated into Spanish and then trans- 
lated back to  ensure accuracy. Specific cognitive func- 
tions assessed and neuropsychological tests administered 
included the following: 
Word list learning and memory. The Selective Re- 
minding Test (SRT)5 was administered to assess verbal 
memory. Subjects were given six trials to learn a list of 
12 unrelated words. To assess long-term retention of the 
word list, 15-minute delayed free recall was assessed, fol- 
lowed by a multiple-choice recognition task. 
Nonverbal memory. A multiple-choice version of the 
Benton Visual Retention Test-Form D (BVRTIZ8 was 
used to assess nonverbal memory. Subjects viewed a geo- 
metric design for 10 seconds. It was then removed from 
view, and the subject was asked to recognize the design 
in a four-choice multiple-choice array. 
Orientation. The 10 orientation items from the Mini- 
Mental State Examination (MMSEIz9 were used to assess 
orientation to  time and place. 
Verbal reasoning. The Similarities subtest of the Wechs- 
ler Adult Intelligence Scale-Revised (WAIS-R),6 which re- 
quires subjects to identify relevant similarities or superor- 
dinate categories for paired items, was administered. 
Nonverbal reasoninp. The Identities and Oddities sub- 
test of the Mattis Dementia Rating Sca1e3O was used to 
assess nonverbal reasoning. In this test, subjects identify 
which two of three visually presented stimuli are the 
same. After all eight triads are completed, the same 
items are administered again, and the subject is required 
to identify the one item that is different. 
Naming. A 15-item version of the Boston Naming 
a test of visual confrontation naming, was used to 
assess word-finding ability. 
Letter fluency. Subjects were instructed to generate 
as many words as possible in 1 minute that began with a 
given letter of the alphabet, excluding proper nouns and 
the same word with different suffixes.31 English-speak- 
ing subjects generated words beginning with the letters 
C, F, and L, while Spanish-speaking subjects generated 
words beginning with the letters P, S, and V. Different 
letters were used for Spanish- and English-speaking sub- 
jects to control for word-frequency differences across the 
two languages. 
Category fluency. All subjects generated exemplars in 
the categories animals, foods, and clothing; 60 seconds was 
allowed for each category. For animal fluency, subjects 
were instructed to name any type of animal but were pro- 
vided superordinate categories (animals from the farm, 
jungle, or ocean, or house pets) to  assist retrieval. For 
clothing and food fluency, subjects were instructed to name 
essentially anything one can wear or eat, respectively. 
Auditorv comprehension. The first six items of the 
Complex Ideational Material subtest of the Boston Diag- 
nostic Aphasia Examination3’ were used to  assess com- 
prehension of spoken language. 
Repetition. Subjects were asked to repeat the high-fre- 
quency phrases from the Boston Diagnostic Aphasia Ex- 
amination Repetition of Phrases s u b t e ~ t . ~ ~  
Visuoconstructional skills. Subjects copied five de- 
signs from the Rosen Drawing Test33 ranging in difficulty 
from simple geometric shapes to overlapping, parallel, 
and three-dimensional figures. 
VisuoperceDtual skills, Subjects matched a target de- 
sign to the same design presented simultaneously in a 
four-choice multiple-choice array containing the target 
along with three distractors. Target stimuli corresponded 
to Form C of the original BVRT.28 
Following each evaluation, medical, historical, and 
neuropsychological data were reviewed at  a diagnostic 
conference of physicians and neuropsychologists, and a 
consensus diagnosis of presence or absence of dementia 
was made. The diagnosis of dementia was based on the 
criteria of the Diagnostic and Statistical Manual of Men- 
tal Disorders, revised third edition,34 and required evi- 
dence of cognitive deficit on the neuropsychological bat- 
tery as well as evidence of impairment in social or occu- 
pational function. Neuropsychological test scores were 
evaluated using a fixed paradigm35: criterion scores were 
applied to each test score, and subjects performing below 
these scores on two of three aspects of memory testing 
(ie, immediate verbal, delayed verbal, or visual memory) 
plus two other cognitive domains (ie, orientation, lan- 
guage, abstract reasoning, or visuospatial skills) were 
considered to have sufficient cognitive deficit to  meet cri- 
teria for dementia. Criterion scores were determined pre- 
viously based upon a review of the performance of 172 
patients and controls who had been evaluated in other 
studies or in our Memory Disorders Clinic. For each test, 
mean scores and variability in each group were in- 
spected, and the score that best separated nondemented 
and demented groups was selected a s  the criterion 
score.35 
Data analysis. We used Cox proportional hazards 
models36 to assess the relative risk (RR) of incident de- 
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Table 1. Baseline characteristics of subjects who did and did not become demented 
Incident 
dementia 
(N = 23) 
No incident 
dementia 
(N = 88) 
Age 
Education 
Sex (% female) 
Language (% Spanish) 




















t = 2.53; p < 0.02 
t = 1.02; NS 
x2 = 1.31; NS 
x2 = 0.00; NS 
t = 1.94; NS 
t = 2.55; p < 0.02 
t = 1 . 8 5 ; ~  < 0.07 
t = 1.28; NS 
UPDRS Unified Parkinson’s Disease Rating Scale total score (motor portion). 
Hamilton Hamilton Depression Rating Scale total score. 
IMC Information-Memory-Concentration Test. 
NS Not significant. 
* Duration of Parkinson’s disease from first symptom to baseline evaluation. 
mentia associated with baseline scores on the neuropsy- 
chological tests. Duration of follow-up was used as the 
timing variable for Cox analyses. For incident dementia 
cases with more than one follow-up visit, we used dura- 
tion from baseline to the first follow-up visit at which de- 
mentia was diagnosed; for subjects who remained free of 
dementia, we used duration from baseline to the last 
available follow-up visit. 
We conducted both exploratory and confirmatory Cox 
analyses. First, to reduce the large number of candidate 
variables in the neuropsychological test battery, we per- 
formed an exploratory analysis using stepwise Cox re- 
gression with backward stepping. Fourteen scores from 
the baseline neuropsychological assessment competed for 
retention in the model. The outcome was incident demen- 
tia, and the criterion for removal from the model was p > 
0.05. The following variables were included in this initial 
analysis: total immediate recall, delayed recall, and de- 
layed recognition from the SRT5; age-corrected scaled 
score from the WAIS-R Similarities subtest6; total num- 
ber of words generated across three trials each of letter31 
and category fluency; and total correct on the Identities 
and Oddities subtest of the Mattis Dementia Rating 
Scale,30 Rosen Drawing Test,33 Benton Visual Retention 
Test2* Matching and Recognition Memory, Boston Nam- 
ing Test: Repetition and Auditory Comprehension from 
the Boston Diagnostic Aphasia E ~ a m i n a t i o n , ~ ~  and the 
MMSE orientation items.29 
We then confirmed the usefulness of the variables re- 
tained in the stepwise analysis by reexamining them in a 
Cox regression with simultaneous entry of variates and 
covariates. In addition to the neuropsychological test 
scores, age, education, sex, and duration of PD symptoms 
were included as covariates. Because our previous inves- 
tigations have shown that severity of motor signs and de- 
pression are significant predictors of incident dementia 
in PD,37 baseline scores on the Hamilton Depression Rat- 
ing Scale and UPDRS also were included as covariates. 
All variables were entered into the model simultane- 
ously; thus, the RR associated with each variable was in- 
dependent of all other variates and covariates. 
Results. One hundred twenty-two PD patients 
who were not demented at the time of their initial 
assessment had completed at least one follow-up 
evaluation. Eleven of these patients were excluded 
from the current analysis because they were miss- 
ing baseline data for one or more of the following 
variables: letter fluency (n = 7), category fluency (n = 
7), Hamilton Depression Rating Scale (n = 61, and 
UPDRS (n = 1). The remaining 111 subjects were 
included in the Cox models. Twenty-three of the 
111 initially nondemented subjects were diagnosed 
with dementia at follow-up. The average duration 
of follow-up was 2.70 (* 1.03) years. 
Baseline characteristics of subjects who did and 
did not become demented are presented in table 1. 
Subjects who subsequently became demented were 
older, had more severe motor symptoms, and had 
more symptoms of depression at baseline than 
those who did not become demented. The two 
groups did not differ significantly in education, sex, 
language spoken, or disease duration. Of note, no 
significant difference was observed on baseline 
scores on the Blessed Information-Memory-Concen- 
tration Test,3s indicating that the two groups were 
comparable in terms of overall level of cognitive 
function at the time of initial assessment. The per- 
centage of patients receiving dopamine agonists 
(83% incident dementia, 75% no dementia) and an- 
ticholinergics (22% incident dementia, 17% no de- 
mentia) for treatment of PD did not differ between 
those who did or did not become demented. 
Four of the 14 neuropsychological variables in the 
stepwise Cox regression were retained after back- 
ward stepping: total immediate recall on the SRT, 
category fluency, letter fluency, and Mattis Identi- 
ties and Oddities. When these four variables were 
entered simultaneously in a Cox regression along 
with the covariates (age, education, sex, Hamilton, 
and UPDRS), the RR of incident dementia associ- 
ated with baseline scores on letter fluency and cate- 
gory fluency remained significant. Total immediate 
recall on the SRT and Mattis Identities and Oddities 
did not contribute significantly to  the model that in- 
cluded the covariates. In the final model, letter and 
category fluency were retained along with the co- 
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Table 2. Risk ratios for incident dementia derived 
from a Cox proportional hazards model with 




Variable ratio interval p Value< 
Age 1.06 
Education 1.01 
Sex (female) 0.73 
Duration of 1.01 
UPDRS total score 1.04 
Hamilton total score 1.11 
Letter fluency (score 3.31 
Category fluency 6.01 
Parkinson’s disease (yr) 
below median) 

















* The risk ratio for each variable represents its associated 
relative risk independent of all other variables in the 
model. 
UPDRS Unified Parkinson’s Disease Rating Scale (motor por- 
tion). 
Hamilton Hamilton Depression Rating Scale. 
I 
variates. To aid in the interpretation of RR values, 
we dichotomized baseline test performance on each 
of the fluency tasks into scores above and below the 
median, and then examined the RR associated with 
obtaining a score below the median. The median 
total score for letter fluency was 27 words; for cate- 
gory fluency the median total was 42 items. RR val- 
ues are presented in table 2. Letter fluency, category 
fluency, age, degree of depressive symptomatology, 
and severity of extrapyramidal signs were signifi- 
cantly and independently associated with incident 
dementia. Education, sex, and duration of PD were 
not significantly associated with incident dementia. 
Discussion. The current results suggest that im- 
paired performance on tests of verbal fluency in PD 
may represent a harbinger of more global and se- 
vere cognitive impairment. Although letter and cat- 
egory fluency tests were originally developed to as- 
sess fluency in aphasic patients, we hypothesize 
that the poor performance of PD patients on these 
tasks does not reflect a primary impairment of lan- 
guage but is a sign of executive dysfunction associ- 
ated with the incipient stages of dementia. To gen- 
erate words efficiently on these tasks, subjects 
must plan and initiate a systematic search of se- 
mantic m e m ~ r y . ~ ~ , ~ ~  
There is discrepancy across previous cross-sec- 
tional studies as to the relative impairment on tests 
of letter versus category fluency in PD patients. 
While some investigators report impairment on 
tests of both letter and category fluency in PD pa- 
tients,12 others report impairment only on letter flu- 
ency tasks,8 while still others report impairment on 
category but not letter fluency.11J3 In the current 
study, we found that both letter and category flu- 
ency tests were sensitive to  the subtle cognitive 
changes associated with preclinical dementia in PD. 
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Relative to age-referenced normative data, PD pa- 
tients who subsequently became demented scored, 
on average, at the 15th percentile on category flu- 
ency and the 20th percentile on letter fluency, while 
those who remained nondemented scored a t  the 
44th percentile on both fluency tasks. Thus, there 
appears to  be a nonspecific impairment on tests of 
verbal fluency in nondemented PD patients who 
later develop clinically significant dementia. 
The discrepant findings of previous cross-sec- 
tional studies comparing letter and category fluency 
tests in PD patients and normal control subjects 
may be due to differences in task demands or in- 
structions across studies. Although specific instruc- 
tions seldom are described in research articles, the 
studies probably used different stimuli (ie, letters 
and categories) and instructions. Letters differ with 
regard to their frequency of occurrence as the initial 
letter of words, and categories differ with regard to 
the number of possible exemplars, so the difficulty 
level of fluency tasks can vary depending upon the 
letters and categories used. Similarly, test instruc- 
tions can alter the difficulty of a task. For example, 
the difficulty of the category fluency test can be 
modified based on whether or not the instructions 
provide superordinate categories as retrieval cues. 
The benefit provided by these more explicit instruc- 
tions may be particularly pronounced for PD pa- 
tients, because these patients often have difficulty 
initiating cognitive strategies for retrieving stored 
information. Randolph et a139 reported significant 
impairment in PD patients relative to  normal con- 
trol subjects on an uncued category fluency task; 
however, the performance of PD patients was nor- 
malized when retrieval cues were provided. Sub- 
jects in the current study were provided with super- 
ordinate categories to assist retrieval; thus, scores 
may have been relatively higher than if an uncued 
fluency task had been administered. Nevertheless, 
performance on the cued category fluency task was 
a good predictor of incident dementia. 
The neuropsychological pattern characterizing 
the preclinical stages of dementia in PD differs 
from that reported in our earlier work describing 
the neuropsychological characteristics of preclinical 
AD in nondemented healthy elderly  subject^.^ Ver- 
bal fluency scores did not predict incident AD in 
healthy elders. Instead, the neuropsychological 
characteristics of preclinical AD were poor immedi- 
ate recall on the SRT,5 visual confrontation naming 
(Boston Naming Test),4 and verbal abstract reason- 
ing (WAIS-R Similarities subtest).6 The PD inci- 
dent dementia patients described here, and the in- 
cident AD patients described previously, scored 
comparably on a mental status screening examina- 
t i ~ n ~ ~  administered at baseline; thus, this disparate 
result between these two subject groups does not 
appear to be attributable to a difference in overall 
severity of cognitive impairment. 
The distinct neuropsychological manifestation of 
preclinical dementia in PD patients and healthy el- 
derly subjects suggests differences in the onset and 
progression of dementia in PD compared with AD. 
Different pathologic substrates may be accounting 
for the differences in test performance between 
these subject groups. Results similar to  those re- 
ported here were observed when we compared non- 
demented and demented PD patients with AD pa- 
t i e n t ~ ~ ~ ;  nondemented and demented PD patients 
performed worse than AD patients on verbal flu- 
ency and visuospatial tasks, even after the PD and 
AD groups were equated for overall level of cogni- 
tive function. We hypothesize that when dementia 
occurs in PD, worsening memory is superimposed 
on cognitive changes that already exist in nonde- 
mented patients, but that the dementing process is 
not due to concomitant AD. As speculated previ- 
o u ~ l y , ~ ~  the difficulties with initiating retrieval of 
information (eg, category exemplars) and generat- 
ing responses exhibited by PD patients may be due 
to striatal dysfunction, while the memory, naming, 
and verbal abstract reasoning deficits in AD pa- 
tients likely reflect cortical degeneration. There are 
several possible causes of dementia in PD, however, 
such as dopamine depletion, cortical Lewy bodies, 
and cortical cholinergic deficiency with or without 
AD pathology. As we have not yet obtained post- 
mortem analyses on the participants in this study, 
we can conclude only that diminished verbal fluency 
might be a precursor of any of these conditions. 
A potential limitation of the current study is that 
the tasks within our neuropsychological test battery 
are not comparable for overall level of difficulty. 
Thus, variations in test sensitivity may have con- 
tributed to the specific profile of deficits tha t  
emerged as being predictive of incident dementia. 
Further, our test battery does not include formal 
measures of “executive function” on which nonde- 
mented patients with PD often perform poorly, such 
as the Wisconsin Card Sorting Test,42 the Stroop 
Test,43 or the Trail Making Test.& These tests might 
have detected additional subtle cognitive changes in 
our nondemented PD patients who subsequently be- 
came demented and might have provided a further 
independent contribution to the prediction of inci- 
dent dementia. As noted above, we hypothesize that 
the poor performance of some PD patients on our 
tests of verbal fluency reflects executive dysfunction. 
In summary, the current study provides evi- 
dence of a preclinical phase in the dementia of PD 
and suggests that the neuropsychological charac- 
teristics of predementia in PD are distinct from 
those previously reported to be associated with pre- 
clinical AD. The divergent cognitive profiles be- 
tween PD and AD patients may reflect different 
pathologic substrates for the dementia syndromes 
associated with these two diseases. 
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Emotional facial imagery, 
perception, and expression 
in Parkinson’s disease 
Daniel H. Jacobs, MD; Jeffrey Shuren, MD; Dawn Bowers, PhD; and Kenneth M. Heilman, MD 
Article abstract-Patients with Parkinson’s disease (PD) may be impaired a t  expressing emotional faces and perceiv- 
ing emotional facial affect. We tested the hypothesis that patients with PD may be impaired a t  imaging emotional 
faces. We first compared 12 patients with PD and 30 control subjects on perceptual and imagery tasks. Patients were 
significantly impaired on a task of emotional facial imagery but not on a control task of object imagery. Patients were 
also impaired on a task of perceiving emotional faces. Subsequently, we found that PD patients were impaired relative 
to controls on making emotional faces. Performance on both the perceptual and motor tasks of facial expression signifi- 
cantly correlated with performance on the emotional facial imagery task. We suggest that the basal ganglia, together 
with the right hemisphere, are part of a neural network subserving emotional facial tasks. 
NEUROLOGY 1995;45:1696-1702 
The formation of mental images is assumed to de- 
pend upon accessing long-term memory stores from 
visual cortical representations.lX2 Initially, Farahl 
proposed that visual representations, used both for 
imagery and for perception, were housed in the 
posterior left hemisphere. However, dissociations 
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